Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ENTREMED
(NQ:
ENMD
)
1.770
USD
-0.010 (-0.56%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
1.760
Bid (Size)
1.760 (2000)
Ask (Size)
1.780 (9600)
Prev. Close
1.780
Today's Range
1.760 - 1.780
52wk Range
1.230 - 3.500
Shares Outstanding
27,023,038
Dividend Yield
N/A
Top News
More News
EntreMed, Inc. New (ENMD) Narrows Q1 Loss
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339331 for the full story.
Read More
from
StreetInsider.com News Articles
EntreMed Reports First Quarter 2013 Financial Results
May 15, 2013
from
PR Newswire
More News
Read More
EntreMed's ENMD-2076 Awarded Patent In China
May 06, 2013
category
Contracts
,
Management
,
ENMD
, and 4 more.
from
Latest Articles from Benzinga.com
Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076
May 06, 2013
from
PR Newswire
Patent Issued In U.S. For EntreMed's 2ME2 In Rheumatoid Diseases
May 03, 2013
from
PR Newswire
EntreMed (ENMD) Appoints Ken Ren as CEO; Names Two Board Members
April 05, 2013
from
StreetInsider.com News Articles
EntreMed Announces Changes to Board of Directors and CEO Appointment
April 05, 2013
from
PR Newswire
EntreMed, Inc. New (ENMD) Swings to Q4 Loss
March 21, 2013
from
StreetInsider.com News Articles
EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
March 21, 2013
from
PR Newswire
The Week in Review: Sinopharm to Raise $640 Million through Bond Sale
March 09, 2013
from
ChinaBio® Today
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.